The development of a next generation NK cell engager platform by integrating a potency-reduced IL-15 variant to enhance antitumor activity
{{output}}
Background: Natural killer cell engager (NKCE) has gained attention recently. Conventional NKCEs exhibit mild anti-tumor efficacy despite acceptable safety profiles. Therefore, next-generation NKCE development is essential to enh... ...
